Tech Company Financing Transactions
Amunix Pharmaceuticals Funding Round
Viking Global Investors, ArrowMark Partners and Avidity Partners participated in a $117 million Series B funding round for Amunix Pharmaceuticals. The round was announced on 3/5/2021.
Transaction Overview
Viking Global Investors (Lead Investor)
Frazier Healthcare Partners (James Brush)
Longitude Capital Management (David Hirsch)
Omega Funds (Otello Stampacchia)
Company Information
San Francisco, CA 94080
USA
Management Team
Browse more venture capital transactions:
Prev: 3/5/2021: Jungle Scout venture capital transaction
Next: 3/5/2021: Webscale venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs